T1	Condition 0 15	Type 1 diabetes
T2	Qualifier 29 42	ADA criterias
T3	Temporal 43 51	<5 years
R1	Has_qualifier Arg1:T1 Arg2:T2	
R2	Has_temporal Arg1:T1 Arg2:T3	
T4	Person 54 57	Age
T5	Value 57 90	= 18 years and less than 70 years
R3	Has_value Arg1:T4 Arg2:T5	
T6	Negation 93 96	Non
T7	Condition 97 102	obese
R4	Has_negation Arg1:T7 Arg2:T6	
T8	Measurement 115 118	BMI
T9	Value 119 137	less than 28 kg/m2
R5	Has_value Arg1:T8 Arg2:T9	
T10	Multiplier 152 164	at least one
T11	Condition 172 197	anti-islet autoantibodies
T12	Condition 199 203	GADA
T13	Condition 205 209	IA2A
T14	Condition 211 216	ZnT8A
*	OR T12 T13 T14
T15	Scope 199 216	GADA, IA2A, ZnT8A
R6	Subsumes Arg1:T11 Arg2:T15	
R7	Has_multiplier Arg1:T11 Arg2:T10	
T16	Measurement 229 258	postprandial plasma C-peptide
T17	Measurement 218 225;242 258	Fasting plasma C-peptide
*	OR T17 T16
T18	Scope 218 258	Fasting or postprandial plasma C-peptide
T19	Value 259 279	more than 100 pmol/L
R8	Has_value Arg1:T18 Arg2:T19	
T20	Informed_consent 281 348	Written informed consent from the patient or family representative.
